Fundraising Fox

Canaan Partners

Venture capital

Stamford · Pre-Seed–Series A · 34 people tracked

Also known as CANAAN MANAGEMENT, LLC · Canaan Natural Gas Management, Llc

Fox Verdict
Sign up to see your fit

Investment thesis

Canaan emphasizes a personal, non-formulaic approach to venture investing, drawing on values built over three decades. The firm prizes high performance with low ego, favoring understated and effective partners over self-promotion. It values a diverse team whose varied backgrounds inform a collective approach spanning industries, generations, and geographies. Canaan positions the full team's network and operational resources behind each portfolio company, helping with recruiting, go-to-market, and strategic pivots. The firm treats founders with respect, transparency, and honesty, viewing portfolio companies like family and tying its own success to theirs. It aims to stay closely informed and add value while knowing when to step back and let founders lead.

Source: firm website, verified Aug 25, 2026.

Stage
Pre-Seed–Series A
Check
$500K – $20M
HQ
Stamford, Connecticut, US
Leads rounds
Leads
Instruments
Equity
Founded
1994
Last 12 months
11 investments
AUM
$7B
VC funds
29
Tracked investments
443

Team · 34 people

from the firm's website & public directories
Hootan Rashidifard· Principalin𝕏
Stephen Green· Venture Partnerin
Howard Greenfieldin
Paul Fonteynein

Founder mafia

3 people who came through Canaan Partners went on to found or lead other companies.

What they invest in

from 220 of 443 portfolio companies

Biotech ×69Healthtech ×56AI & Machine Learning ×52SaaS ×49Enterprise Software ×39Fintech ×32Medical Devices ×30Data & Infrastructure ×22

HQs:United States×176United Kingdom×8Canada×3Nigeria×3Belgium×1Switzerland×1

Who they back

founder profiles across 114 portfolio companies
54%
solo founders
62 of 114 mapped founding teams
46%
repeat founders
of 81 founders with career history
~3 yrs
old at investment
median across 48 dated deals

Founding team size:solo founder×622 founders×353 founders×124+ founders×5

Where their founders studiedfrom 76 founders with education data

Massachusetts Institute of Technology ×3McGill University ×3Stanford University Graduate School of Business ×3University of California, Berkeley, Haas School of Business ×3University of Illinois Urbana-Champaign ×3University of Southern California ×3Babson College ×2California Polytechnic State University-San Luis Obispo ×2

Where their founders worked beforefrom 81 founders with career history

Apple ×4AOL ×3Cisco ×3Meta ×3Stanford University ×3Airtime ×2eAssist Global Solutions ×2Georgia Institute of Technology ×2

Accelerator rootsportfolio companies that came through a program

Y Combinator ×6Techstars ×2

12 founders hold a PhD · 15 hold an MBA (of 80 with degree data)

Investments · 443 tracked

founders shown can be your intro path

By year:2026 · 82025 · 142024 · 92022 · 12021 · 82020 · 82019 · 22018 · 72017 · 82016 · 82015 · 222014 · 11111 dated

Arvinas Holding Co. LLCarvinas.comin𝕏NASDAQ: ARVNOct 2015

Arvinas develops targeted protein degradation therapies using its PROTAC (PROteolysis TArgeting Chimeras) platform, which harnesses the body's natural protein disposal system to degrade disease-causing proteins.

BiotechHealthtechNew Haven, US

Sean Cassidy(Executive Officer)Manuel Litchman(Executive Officer, Director)

BoardStephen Squinto(Director)inLiam Ratcliffe(Director)Kush Parmar(Director)

Board seatTim Shannon· per SEC Form D

Co-investors5AM VenturesAccess BiotechnologyConnecticut InnovationsNextech InvestRA CapitalSolasta Ventures+1 more

Cardlyticscardlytics.comin𝕏NASDAQ: CDLXMay 2017

Cardlytics operates a commerce media platform that uses card-linked purchase data to deliver targeted offers and closed-loop measurement for marketers and advertisers, and personalized rewards programs for banks and publishers.

AdTechFintechMarketing TechAtlanta, US

Scott Grimes(Executive Officer, Director)inLynne Laube(Executive Officer, Director)Kirk Somers(Executive Officer)David Evans(Executive Officer)

BoardJohn Klinck(Director)inMark Johnson(Director)in

Board seatJohn Balen· per SEC Form D

Co-investorsBaroda VenturesKinetic Ventures, L.L.C.Next Coast VenturesSavano Capital PartnersHyperplane Venture CapitalPolaris Partners+1 more

CytomX TherapeuticsNASDAQ: CTMXDec 2014SEC filingmedium confidence

Clinical-stage biotechnology company developing conditionally activated, masked biologics designed to be localized to the tumor microenvironment.

BiotechSouth San Francisco, US

Sean McCarthy(Executive Officer, Director)

BoardElaine V. Jones(Director)Neil Exter(Director)inFrederick W. Gluck(Director)Hoyoung Huh(Director)

Board seatTim Shannon· per SEC Form D · $30M raise · filed Jan 2015

Co-investorsLongitude CapitalThird Rock Ventures

Liquidia Corporationliquidia.comNASDAQ: LQDAApr 2021

BiotechMorrisville, US

Damian deGoa(Executive Officer, Director)Michael Kaseta(Executive Officer)

BoardPaul B. Manning(Director)Joanna Horobin(Director)Raman Singh(Director)

Board seatStephen Bloch· per SEC Form D

Co-investorsNew Enterprise Associates (NEA)PBM Capital

Liquidia TechnologiesNASDAQ: LQDAFeb 2018SEC filingmedium confidence

BiotechMorrisville, US

Kevin Gordon(President and Chief Financial Officer)Robert Lippe(Chief Operations Officer)Benjamin Maynor(Senior Vice President, Research and Development)Timothy Albury(Executive Officer)Neal F. Fowler(Chief Executive Officer)

Board seatStephen Bloch· per SEC Form D · $22.4M raise · filed Jan 2020

Co-investorsPappas Capital

Nextcurenextcure.comNASDAQ: NXTCDec 2015

Nextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.

BiotechBeltsville, US

Timothy Mayer(Executive Officer)Michael Richman(Executive Officer, Director)Elaine V. Jones(Director)Udayan Guha(Executive Officer)Anne Borgman(Director)Steven P. Cobourn(Executive Officer)

Board seatTim Shannon· per SEC Form D

Co-investorsLAVLilly Asia VenturesPfizer Venture InvestmentsQuan CapitalSofinnova VenturesTaiho Ventures, LLC+1 more

Rallybio HoldingsNASDAQ: RLYBMar 2020SEC filingmedium confidence

HealthtechFarmington, US

Jeffrey M. Fryer(Executive Officer, Director)Martin W. Mackay(Executive Officer, Director)Stephen Uden(Executive Officer, Director)

Board seatTim Shannon· per SEC Form D · $145.2M raise · filed May 2020

TYRA Biosciencestyra.bioinNASDAQ: TYRAFeb 2024SEC filingmedium confidence

Tyra is developing oral dabogratinib, a small-molecule therapy being evaluated in clinical studies for skeletal dysplasia and urologic cancers.

BiotechHealthtechCarlsbad, US

Todd Harris, Ph.D.(Executive Officer, Director)Hiroomi Tada, M.D., Ph.D.(Executive Officer)Daniel Bensen(Executive Officer)Alan Fuhrman(Executive Officer)

BoardRobert More(Director)

Board seatNina Kjellson· per SEC Form D · $200M raise · filed Feb 2024

Co-investorsAlta PartnersBioBritNextech Invest

Aevaaeva.comin𝕏NASDAQ: AEVAJan 2017

Aeva develops FMCW-based 4D LiDAR sensors and perception software that detect velocity and range simultaneously, using silicon photonics to integrate LiDAR elements on a chip.

Enterprise SoftwareFintechHardwareMobility & TransportationSaaSSemiconductorsPalo Alto, US

SOROUSH SALEHIAN DARDASHTI(Executive Officer, Director)MINA REZK(Executive Officer, Director)Soroush Salehian(CEO and Cofounder)

BoardSHAHIN FARSHCHI(Director)Yuan Chen(Capital Allocator)inSimon Mahony(Investor)

Co-investorsLux CapitalNext47Socii Capital

DexComdexcom.cominNASDAQ: DXCMMay 2016

Dexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Richard Doubleday(Executive Officer)Steven R. Pacelli(Executive Officer)Jeffrey Moy(Executive Officer)Terrance H. Gregg(Executive Officer, Director)Jorge Valdes(Executive Officer)John D. Lister(Executive Officer)

Ideaya Biosciencesideayabio.comin𝕏NASDAQ: IDYA

IDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers.

BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US

Yujiro Hata(Executive Officer, Director)Paul Stone(Executive Officer)

BoardTimothy Shannon(Director)inJohn Diekman(Director)inTerry Rosen(Director)Jeffrey Stein(Director)

Co-investors5AM VenturesNextech Invest

Instacartinstacart.comin𝕏NASDAQ: CART

Instacart operates a marketplace connecting grocery retailers with customers who order food and household items for same-day delivery or in-store pickup, serving millions of households across North America through partnerships with over 350 retailers.

ConsumerE-commerceFoodTechSan Francisco, US

Apoorva Mehta(Founder & CEO)inBrandon Leonardo(Founder)inMax Mullen(Founder)in

Co-investorsA*Andreessen HorowitzBACKGROUND CAPITALBling CapitalBright Pixel CapitalCoatue Management+28 more

Matchmatch.comNASDAQ: MTCH

Gary Kremen(Founder)inSpencer Rascoffin

NextCureNASDAQ: NXTC

Co-investorsBay City CapitalPfizer Venture Investments

Protagonist Therapeuticsprotagonist-inc.comin𝕏NASDAQ: PTGXJul 2015

Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.

BiotechHealthtechMilpitas, US

Dinesh V. Patel, PhD(Executive Officer, Director)Dinesh Patel(President & Chief Executive Officer)

BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)Paul F. Truex(Director)

Co-investorsAisling CapitalJJDCLilly VenturesStarfish Ventures

Rallybio, LLCrallybio.comin𝕏NASDAQ: RLYB

Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.

BiotechHealthtechNew Haven, US

Steve Uden(Co-Founder & Chief Executive Officer)Stephen Uden(Founder)inMartin(Co-Founder & Chairman)Jon(Chief Financial Officer)

Co-investors5AM VenturesConnecticut InnovationsF-Prime CapitalMitsui Global InvestmentSolasta Ventures

Arrakis Therapeuticsarrakistx.comin𝕏Feb 2017✓ verified

Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

Michael Gilman(Executive Officer, Director)Mark DeLong(CEO)David Neafus(Executive Officer)Russell C. Petter(Executive Officer)

BoardAlan E. Walts(Director)in

Board seatColleen Cuffaro· per SEC Form D

Co-investorsPfizer VenturesAdvent Life SciencesNextech InvestOUP (Osage University Partners)Pfizer Venture InvestmentsvenBio Partners+1 more

Iantrekiantrekmed.cominOct 2020✓ verified

Iantrek develops micro-interventional surgical technology using allogeneic biotissue to create a category it calls Bio-intervention for treating chronic eye disease.

BiotechHealthtechMedical DevicesElkins Park, US

Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))Michael Haydin(Executive Officer)

BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)

Board seatStephen Bloch· per SEC Form D

Co-investorsaMoonVisionary VenturesCivilization Ventures Management, LlcFemHealth VenturesJSD Capital, LLCUS Venture Partners

Nocion Therapeuticsnociontx.comin𝕏Dec 2025✓ verified

Nocion Therapeutics develops small molecule charged sodium channel blockers (nocions) designed to silence overactive sensory nerves.

BiotechHealthtechMedical DevicesWatertown, US

MATTHEW FRANKEL(Executive Officer)PETER COUROSSI(Executive Officer)RICHARD BATYCKY(Executive Officer, Director)JAMES ELLIS(Executive Officer)MICHAEL LIPP(Executive Officer)CHRISTOPHER SILBER(Executive Officer)

Board seatJulie Grant· per SEC Form D

Co-investorsF-Prime CapitalMission BiocapitalMonograph Capital PartnersOUP (Osage University Partners)Osage University Partners

Vivace Therapeuticsvivacetherapeutics.comFeb 2025✓ verified

Vivace Therapeutics is an oncology-focused drug discovery and development company creating small-molecule inhibitors targeting the Hippo-YAP pathway to treat cancers including mesothelioma, meningioma, and various other tumor types.

BiotechHealthtechMedical DevicesSan Mateo, US

Shuang Qiao(Executive Officer, Director)Sheng Ding(Executive Officer)

BoardEdward Hu(Director)Jun Wu(Director)Jake Simson(Director)in

Board seatTim Shannon· per SEC Form D

Co-investorsRA CapitalCenova CapitalMission Biocapital

Acesion Pharma ApSacesionpharma.comin✓ verified

Acesion Pharma is a biotech company developing pharmaceutical treatments.

BiotechHealthtechMedical DevicesCopenhagen, DK

Anders Gaarsdal Holst(CEO & CMO)Ulrik Sørensen(COO & Co-founder)Morten Grunnet(CSO & Co-founder)Torgeir Vaage(CFO)

Co-investorsAlpha Wave GlobalNovo HoldingsBroadview VenturesGlobal BioAccess Fund

AttoTudeattotude.comin✓ verified

AttoTude develops optical interconnect technology for data centers to support artificial intelligence and exascale computing applications.

AI & Machine LearningData & InfrastructureDeep TechHardwareMenlo Park, US

David F. Welch(Co-founder)Joy Laskar(Co-founder)Dave Welch(Founder)in

BoardPeter Wagner(Director)Basil Alwan(Director)

Co-investorsThe Westly GroupSutter Hill VenturesMayfield FundNosTerra Venture CapitalOpen Field CapitalWing+1 more

ThirtyFiveBio Limitedthirtyfivebio.comin✓ verified

ThirtyFiveBio is a drug discovery company developing GPR35 antagonists to treat gastrointestinal diseases, with a focus on ulcerative colitis by targeting epithelial dysfunction.

BiotechDigital HealthHealthtechOxford, GB

James Westcott(CEO)

Tizona Therapeutics, Inc.tizonatx.com✓ verified

Tizona Therapeutics is a biotechnology company developing first-in-class immuno-oncology therapeutics, including its lead clinical-stage asset TTX-080, aimed at changing cancer progression and relapse.

AI & Machine LearningBiotechHealthtech

Vijay K. Kuchroo(Scientific Co-Founder & Advisory Board Member)Drew Pardoll(Scientific Co-Founder & Advisory Board Member)Dario Vignali(Scientific Co-Founder & Advisory Board Member)Jedd Wolchok(Scientific Co-Founder & Advisory Board Member)Christine O'Brien(Chief Executive Officer & Board Member)Courtney Beers(Chief Scientific Officer)

Co-investorsMPM BioImpactAbingworthGilead SciencesAstellas Venture Management LLCLightstone Ventures

Trishula Therapeutics, Inc.trishulatx.comin✓ verified

Trishula Therapeutics is a clinical-stage biopharmaceutical company developing TTX-030, a first-in-class anti-CD39 antibody for advanced cancers.

BiotechHealthtech

Anil Singhal(President and CEO)Siddhartha Mitra(Chief Medical Officer)

Co-investorsMPM BioImpactAstellas Venture Management LLCLightstone Ventures

Aer Therapeuticsaertherapeutics.cominJan 2025

Aer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma.

BiotechHealthtechMedical DevicesRaleigh, US

THOMAS MATHERS(Executive Officer, Director)James Shaffer(Executive Officer, Director)John Fahy(Director)inThomas Mathers(Executive Officer, Director)Evan Caplan(Director)in

BoardChristy Shaffer(Director)in

Board seatTim Shannon· per SEC Form D

Co-investorsHatteras Venture PartnersOrbiMedPappas Capital

Agile Stacks Inc.Dec 2016SEC filingmedium confidence

San Mateo, US

Board seatMaha Ibrahim· per SEC Form D · $3.1M raise · filed Mar 2017

AlcheraOct 2021SEC filingmedium confidence

HealthtechWalnut Creek, US

Lester John Lloyd(Previously CEO, now Chairman & Director.)Andrew Thomas Lloyd(General Counsel, Corp Sec'y)Ken Traverso(CEO, Director)Donald Shirley(President, Director)Timothy Patrick Lloyd(CTO, Director)

Board seatWende Hutton· per SEC Form D · filed Nov 2021

Alphina Therapeuticsalphinatx.comFeb 2026

Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.

BiotechNew Haven, US

Barbara Fox(Executive Officer, Director)Nicholas J Galli(Executive Officer, Director)Kevin L. Rakin(Executive Officer, Director)Stanley Choy(Executive Officer)Ranjit Bindra(Director)

Board seatColleen Cuffaro· per SEC Form D

Co-investorsConnecticut InnovationsHighCape CapitalOUP (Osage University Partners)

Annum HealthOct 2016

Evidence-based teletherapy platform addressing alcohol use disorder.

HealthtechNew York, US

Lauren Wolfe(Executive Officer)Mark Willenbring(Executive Officer)Michael Laskoff(Executive Officer, Director, Promoter)

BoardManish Agarwal(Director)Miki Kapoor(Director)

Board seatNina Kjellson· per SEC Form D

Co-investors.406 VenturesARC Angel FundAXA Venture PartnersElevate Innovation Partners

Antiva Biosciencesantivabio.cominMay 2015

Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.

BiotechFemTechHealthtechMedical DevicesRedwood City, US

Gail Maderis(Director)Kristine Ball(Executive Officer, Director)Elaine Chien(Executive Officer)Sarah Walter(Executive Officer)Raju Gadiraju(Executive Officer)John Sayward(Executive Officer)

Board seatWende Hutton· per SEC Form D

Co-investorsAdjuvant CapitalBrace PharmaLumira VenturesMPM BioImpactOUP (Osage University Partners)Sofinnova Ventures+2 more

Apex Aiapex.aiinNov 2018

Apex.AI develops safety-certified, scalable software for mobility systems, including its Apex.OS product (with Apex.Grace runtime SDK and Apex.Ida communication middleware) to help build software-defined vehicles.

AI & Machine LearningDeveloper ToolsMobility & TransportationRoboticsSaaSPalo Alto, US

Jan Becker(Executive Officer, Director, Promoter)Dejan Pangercic

Board seatRayfe Gaspar-Asaoka· per SEC Form D

Co-investorsLightspeed Venture PartnersVolvo Group Venture Capital ABAirbus VenturesInMotion VenturesToyota VenturesWebb Investment Network

Butterfly HealthApr 2015SEC filingmedium confidence

Advanced ManufacturingLos Gatos, US

Kelly Lewis Brezoczky(Executive Officer, Director)Paul Crawley(Executive Officer)

BoardDavid Alberga(Director)Karl P Ronn(Director)

Board seatWende Hutton· per SEC Form D · $3.1M raise · filed May 2015

Cargomaticcargomatic.comJan 2015

Cargomatic runs a US marketplace matching shippers with local short-haul, drayage, LTL and white glove trucking capacity.

Marina Del Rey, US

Brett Parker(Executive Officer, Director)Jonathan Kessler(Executive Officer, Director)

Board seatHrach Simonian· per SEC Form D

Co-investorsAcequia Capital (AceCap)eGateway CapitalGreen Meadow VenturesKombo VenturesRachel Zoe VenturesRPS Ventures+10 more

Chrono Therapeuticschronothera.comAug 2016SEC filingmedium confidence

HealthtechHayward, US

GUY DIPIERRO(Director)ALAN LEVY, PH.D.(Executive Officer, Director)ANTHONY RIMAC(Executive Officer)ALAN LEVY(Executive Officer, Director)

BoardELIZABETH ROCKETT(Director)

Board seatWende Hutton· per SEC Form D · $47.6M raise · filed Sep 2016

Co-investorsEmergent Medical Partners, LLPFountain Healthcare PartnersKaiser Permanente VenturesMission Bay Capital

Cidara Therapeuticscidara.comin𝕏Feb 2015SEC filingmedium confidence

Pharmaceutical company developing medicines and vaccines for patient health and treatment.

BiotechHealthtechSan Diego, US

Jeffrey Stein(Executive Officer, Director)Kevin Judice(Director)Kevin Forrest(Executive Officer)Dirk Thye(Executive Officer)Ken Bartizal(Executive Officer)Paul Daruwala(Executive Officer)

Board seatNina Kjellson· per SEC Form D · $42M raise · filed Feb 2015

Co-investors5AM VenturesAisling CapitalBain Capital Life SciencesFrazier Life SciencesRA CapitalVivo Capital+1 more

Clutch Technologies Inc.Jan 2025SEC filingmedium confidence

Toronto

DAN PARK(Executive Officer, Director)STEPHEN SEIBEL(Executive Officer)

BoardAnshul Ruparell(Director)in

Board seatLaura Chau· per SEC Form D · $40.4M raise · filed Jan 2025

Co-investorsFJ Labs

Confetti CollectiveJan 2019SEC filingmedium confidence

New York, US

Sara Raffa(Executive Officer, Director)Linden Ellis(Executive Officer, Director)

Board seatLaura Chau· per SEC Form D · $2.3M raise · filed Feb 2019

Day One Biopharmaceuticalsdayonebio.comin𝕏Feb 2021

Day One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors.

BiotechHealthtechSouth San Francisco, US

Jeremy Bender(Executive Officer, Director)

BoardMichael Gladstone(Director)inDerek DiRocco(Director)inJulie Papanek Grant(Director)inJohn Josey(Director)Daniel Becker(Director)

Board seatJulie Grant· per SEC Form D

Co-investorsAccess BiotechnologyAtlas VentureRA CapitalThe Column Group

Dicom GridMar 2016SEC filingmedium confidence

Phoenix, US

MORRIS PANNER(Executive Officer, Director)MICHAEL PALIN(Chief Financial Officer)STEVEN YECIES(Director)MICHAEL V WALL(Director)GEOFFREY CRAWSHAW(Executive Officer)

BoardSTEPHEN PAPADOPOULOS(Director)

Board seatStephen Bloch· per SEC Form D · $7.4M raise · filed Nov 2017

Dragos websitedragos.cominOct 2018

Dragos provides cybersecurity software, threat intelligence, and professional services to protect operational technology (OT), IT, and IoT assets in industrial environments.

CybersecurityDefense TechEnterprise SoftwareHanover, US

Robert M. Lee(CEO and co-founder)in

Board seatJoydeep Bhattacharyya· per SEC Form D

Co-investorsAllegisCyber CapitalBYU Cougar CapitalCyber Mentor FundDataTribeEarth FoundryEnergy Foundry+8 more

Eiger BiopharmaceuticalsApr 2011SEC filingmedium confidence

BiotechSanta Clara, US

Jeffrey Glenn(Director)David Cory(Executive Officer, Director)

BoardEd Engleman(Director)

Board seatNina Kjellson· per SEC Form D · $3M raise · filed Apr 2016

Co-investorsPfizer Venture InvestmentsVivo Capital

EndoGastric Solutionsendogastricsolutions.comin𝕏Apr 2015

EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.

BiotechHealthtechMedical DevicesSan Mateo, US

Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Guy Jordan(Director)Floyd Loop, M.D.(Director)Josh DeFonzo(Executive Officer)

Board seatBrent Ahrens· per SEC Form D

Co-investorsAccelmed PartnersEvidity Health CapitalLightstone VenturesVCFA GroupDe Novo VenturesFOUNDATION MEDICAL PARTNERS+1 more

Envisia TherapeuticsOct 2015SEC filingmedium confidence

BiotechMorrisville, US

Ben Yerxa(Executive Officer)Eric Linsley(Executive Officer)

BoardEd Mathers(Director)inSeth Rudnick(Director)inNeal Fowler(Director)

Board seatStephen Bloch· per SEC Form D · $5.1M raise · filed Oct 2015

Co-investorsNew Enterprise Associates (NEA)Pappas Capital

Even Financialevenfinancial.cominFeb 2017

Engine by Gen (formerly Even Financial) operates an embedded finance marketplace platform that matches consumers with real-time, personalized financial product recommendations from a network of providers across mobile apps, websites, and other touchpoints.

B2B MarketplacesFintechMarketing TechSaaSBrooklyn, US

Phill Rosen(Founder & CEO)Ian Rosen(Executive Officer, Director)Jarid Maged(Executive Officer, Director)

Board seatBrendan Dickinson· per SEC Form D

Co-investorsAAF Management Ltd.Conversion CapitalF-Prime CapitalGreatPoint VenturesMassMutual VenturesValuestream Ventures+4 more

Fast LabsMar 2014SEC filingmedium confidence

Marina Del Rey, US

Matt Munson(Executive Officer, Director)

BoardMat Ellis(Director)Wyatt Jenkins(Director)

Board seatMaha Ibrahim· per SEC Form D · $18M raise · filed Jun 2018

Genome Medical Holding CoMay 2018SEC filingmedium confidence

HealthtechSouth San Francisco, US

Lisa Alderson(Executive Officer, Director)Randal Scott(Director)Jill Davies(Executive Officer, Director)Elizabeth Moreno(Executive Officer)Mark Sylvester(Executive Officer)Robert Green(Director)

Board seatStephen Bloch· per SEC Form D · $223.2K raise · filed Aug 2018

Co-investorsEcho Health VenturesIllumina Innovation

Glookoglooko.comin𝕏Mar 2021

Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring.

Digital HealthHealthtechSaaSPalo Alto, US

Clay Davidson(Executive Officer)inPrakash Menon(Executive Officer)inEd Marshall(Executive Officer)David Pass(Executive Officer)Adam Hameed(Executive Officer)Mark Beucler(Executive Officer)in

Board seatWende Hutton· per SEC Form D

Co-investorsHealth Catalyst CapitalSamsung Next

Hyalexhyalex.comin𝕏May 2017

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.

HealthtechMedical DevicesLexington, US

Carl Vause(Executive Officer, Director)Mira Sahney(Executive Officer, Director)David Myung(Director)

BoardMichael Hawkins(Director)William Harrington(Director)in

Board seatWende Hutton· per SEC Form D

Co-investorsOUP (Osage University Partners)Treo Ventures, Llc

JOORjoor.comin𝕏Jun 2021

JOOR is a digital wholesale platform connecting brands and retailers globally for buying and selling fashion products.

B2B MarketplacesE-commerceRetail TechSaaSNew York, US

Kristin Savilia(Executive Officer, Director)

BoardDan Ciporin(Director)Michael Brown(Director)inEd Neumann(Director)

Board seatMaha Ibrahim· per SEC Form D

Co-investorsAkkadian VenturesBattery VenturesEastward Capital PartnersGreat Oaks Venture CapitalMultiplier CapitalRed Sea Ventures

Journey Meditationjourneymeditation.cominApr 2025

Journey provides a proactive workplace mental health program designed to identify and address employee mental health risks earlier than traditional employee assistance programs, reducing costs and preventing escalation.

HR TechMental HealthNew York, US

Stephen Sokoler(Executive Officer, Director)

BoardJoshua Siegel(Director)

Board seatBrendan Dickinson· per SEC Form D

Co-investorsBetaworksNelstone VenturesNew York Venture Partners37 AngelsBDMIThe Fund

Komprisekomprise.comin𝕏Apr 2015

Komprise provides analytics-driven unstructured data management and mobility software that helps enterprises analyze, tier, and move file and object data across storage systems and the cloud, including curating data for AI.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareCampbell, US

Krishna Subramanian(Executive Officer, Director, Promoter)inKumar Goswami(Executive Officer, Director, Promoter)inMike Peercy(Founder)in

BoardLip Bu Tan(Director)in

Board seatMaha Ibrahim· per SEC Form D

Co-investorsCelesta CapitalCelesta CapitalMultiplier Capital

Kustomerkustomer.comin𝕏Nov 2019

Kustomer is an AI-native customer experience (CX) platform that ties every interaction to a complete customer record so AI and human agents can respond with full context, automate conversations, and manage support workflows.

AI & Machine LearningEnterprise SoftwareSaaSSales TechShort Hills, US

Jeremy Suriel(Director, Promoter)inBrad Birnbaum(Founder)inMichael Chapin(Executive Officer, Promoter)

BoardScott Beechuk(Director)inAlex Bard(Director)inNeeraj Agrawal(Director)in

Board seatDeepak Kamra· per SEC Form D

Co-investorsAcurio VenturesBattery Venturesboldstart venturesCisco InvestmentsCoatue ManagementNorwest Venture Partners+3 more

LyceraJun 2015DefunctSEC filingmedium confidence

Ann Arbor-founded biopharmaceutical company developing small molecule immunomodulators for autoimmune diseases and cancer.

BiotechAnn Arbor, US

Paul Sekhri(Executive Officer)Gary Glick(Executive Officer, Director)Steve Gillis(Director)Kathleen M. Metters(Executive Officer, Director)

BoardRobert Kamen(Director)inMichael Hayden(Director)

Board seatNina Kjellson· per SEC Form D · filed Jun 2015

Co-investorsARCH Venture PartnersThird Rock Ventures

Minimally Invasive DevicesFeb 2015SEC filingmedium confidence

HealthtechColumbus, US

Wayne Poll(Executive Officer, Director)Renee Albarano(Executive Officer)Caroline Crisafulli(Executive Officer)

BoardFred M. Schwarzer(Director)

Board seatWende HuttonBrent Ahrens· per SEC Form D · $14.1M raise · filed Nov 2015

Myndmynd.coin𝕏May 2018

Mynd offers full-service property management for single-family rental investors, handling tenant placement, leasing, maintenance, and communications, with a tech-based investor portal for real-time portfolio visibility.

Enterprise SoftwareFintechPropTechSaaSOakland, US

Colin Wiel(Executive Officer, Director)Doug Brien(Executive Officer, Director)

BoardRichard Boyle(Director)in

Board seatRich Boyle· per SEC Form D

Co-investorsQEDJackson Square VenturesLightspeed Venture PartnersQED InvestorsR136 VenturesThirdstream Partners

Notable FinanceMay 2026SEC filingmedium confidence

Stamford, US

Leigh Stephenson Browne(Executive Officer)Amy Malone(Executive Officer)Ryan Gillette(Executive Officer)Eugene Didenko(Executive Officer)Austin Lane(Executive Officer, Director)

BoardClare Tokheim(Director)

Board seatLaura Chau· per SEC Form D · $2M raise · filed Jul 2026

nTopologyntopology.comin𝕏Jun 2020

nTop (nTopology) makes parametric engineering design software that lets teams generate, explore, and validate complex geometry with manufacturing constraints and embedded FEA/CFD simulation built into the workflow.

Advanced ManufacturingDeep TechEnterprise SoftwareSaaSNew York, US

Gregory Schroy(Executive Officer, Director, Promoter)Bradley Rothenberg(Executive Officer, Director, Promoter)

Board seatHrach Simonian· per SEC Form D

Co-investorsCrunchFundNotation CapitalPathbreaker VenturesRoot Ventures Manager, LlcTuesday Capital1517+3 more

Olliemyollie.comMar 2024acquired by Agrolimen

Ollie provides personalized fresh dog food recipes crafted by chefs and food scientists, paired with health monitoring services that analyze dog wellness indicators to optimize nutrition and health outcomes for pet owners.

ConsumerFoodTechNew York, US

Nick StaffordinDan Ciporin(Director)Alexandre Douzet(Executive Officer, Director)Steve Marton(Director)

BoardBenjamin Sun(Director)

Board seatLaura Chau· per SEC Form D

Co-investorsARC Angel FundCorrelation VenturesDarco CapitalFelicis VenturesInterplay Ventures Early Stage Management LlcLerer Hippeau+3 more

OncoResponseoncoresponseinc.comApr 2025

Clinical-stage immuno-oncology company developing antibodies derived from the immune systems of 'Elite' cancer responders.

BiotechHouston, US

Alice Bexon(Executive Officer)Clifford J. Stocks(Director, Executive Officer)Kamal D. Puri(Executive Officer)Chris Russell(Executive Officer)Russ Hawkinson(Executive Officer)

BoardSteven Gillis(Director)in

Board seatWende Hutton· per SEC Form D

Co-investors3B Future Health FundGreatPoint VenturesRiverVest Venture PartnersARCH Venture PartnersQatar Investment AuthorityYonjin Venture LLC

Browse all 443 investments with full details →

243 more tracked companies

Edge ImpulseEdgeImpulseElevation PharmaceuticalsEmbrokerEmissaryEmissaryEngine by MoneyLionEnpirionEnterpretEnvisiaEon LaboratoriesEphemeralEsperion TherapeuticseStampEverdream CorporationExecthreadExecThread, Inc.Field AIFireflies AiFLA HoldingsForteFrame TechnologyFxlabsGen.GGenomeGenome MedicalGenome Medical, Inc.GenVecGoodwin CompanyGrey Wolf TherapeuticsGrokStyleGroundWork Open SourceHabeasHalda TherapeuticsHermeusHermeus Mach 5 engineHeyMiloHighriseHomeisHomeis exitedHugoHuman SecurityHyalex OrthopaedicsID AnalyticsImmunicon CorporationInstante SoftwareInstrumentalIntelliCareInteract CommerceInternational Network ServicesIntralinksIntrawareIntrepidiaBioiPrint TechnologiesIstante SoftwareItalicIterum TherapeuticsJinaJina AIJobDirectJobdirect ComJoinJoin DigitalJOORJumpcutJunoKabamKabamKalpanaKeplerKepler CommunicationsKickpayKin EuphoricsKinecta CorporationLabrys BiologicsLadderLancopeLatitude CommunicationsLeanplumLeap To Win TechnologiesLeap To Win Technologies Private LimitedLending ClubLendingClubLevLily AIliveramp.com/ (opens in new tab)LiveUMachEyeMani.MeManiMeMariner Health GroupMarinus PharmaceuticalsMarvinMarvinMatch.comMate SecurityMatrimony ComMatrix PharmaceuticalMC SciencesMetacloudMightyTVMindTickleMiraMobilitecMoseyMoviePassMschf Product Studio IncNetwork EnginesNivoda LimitedNocionNormunityNorthstar NeuroscienceNova LabsNoveeNoveeNovee SecurityNovira TherapeuticsOllieOn DeckON24OncolineaOncoLinea PharmaceuticalsondeckOnDemandOnefinestayOnePipeOneSource ServicesONI Systems CorporationOnramp Payments, Inc.OpenartOpenSkyOrapharma IncOrchardOrthocon, Inc.Page Technologies, Inc.PapaPartiful CoPathios TherapeuticsPaxosPeer39Peninsula PharmaceuticalsPlayers' LoungePlixiPodzPozenPraecis PharmaceuticalsPrax HealthPremier Laboratory ServicesPrimeSenseProperty CapsuleProvenance Technologies, Inc.Quarry TheraRADD PharmaceuticalsRally Network, Inc.RamReRapidataReactive BioReactive BiosciencesReflexReflex Careers, Inc.ReibusReplicantRevivantRightPointRLY NetworkRLY NetworkRoRocketripRondo Therapeutics, Inc.RyloSafireSageOxSandforceSavvySemnur PharmaceuticalsSensageShara Inc.ShopKeepSidechatSilicon OptixSilverRailSitterSkale LabsSkybox ImagingSnykSolvelySolvely AiSpectrianSpinifex PharmaceuticalsSuccessFactorsSuiza FoodsSumbleSuperplasticSwitchflySynthekineTacit NetworksTallanTaptap SendTariTelariaTelitTerretThe InsideThe MetaThe RealrealTiaTobira TherapeuticsTomorrow IoTremorTriton Therapeutics, Inc.TropicTropic BiosciencesTrueFortTubular LabsTuroTuro (RelayRides)Twenty20TyraUnifiUniform TeethURoamValidVedana Therapeutics, Inc.VictoriousVima Therapeutics, Inc.Virsto SoftwareVirtuoso Therapeutics, Inc.Visigenic SoftwareVisipriseVoyenceVue TechnologyWebloyaltyWebloyalty ComWiseLayerwithcoWizRocket, Inc. (d/b/a CleverTap)WonderhillWorkMotionWorld ViewXirrusZANDIVIO LTD (d/b/a Uniform Teeth)ZmandaZugata

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 20

IPOs and acquisitions across the tracked portfolio

Arvinas Holding Co. LLCNASDAQ: ARVNCardlyticsNASDAQ: CDLXCytomX TherapeuticsNASDAQ: CTMXLiquidia CorporationNASDAQ: LQDALiquidia TechnologiesNASDAQ: LQDANextcureNASDAQ: NXTCRallybio HoldingsNASDAQ: RLYBTYRA BiosciencesNASDAQ: TYRAAevaNASDAQ: AEVADexComNASDAQ: DXCMIdeaya BiosciencesNASDAQ: IDYAInstacartNASDAQ: CARTMatchNASDAQ: MTCHNextCureNASDAQ: NXTCProtagonist TherapeuticsNASDAQ: PTGXRallybio, LLCNASDAQ: RLYBOllieacq. by AgrolimenAim Securityacq. by Cato NetworksBeckonacq. by IgniteTecheBatesacq. by Rakuten

Portfolio news

latest coverage across their companies

Fund performance · per public LP disclosures · 9

as of Jun 2025
FundVintageCommittedNet IRRTVPIDPI
Canaan XIII Healthcare Fund L.P.LPs: California Public Employees' Retirement System20240.59x0.00x
Canaan XIII L.P.LPs: California Public Employees' Retirement System20240.90x0.01x
Canaan Gold Coast L.P.LPs: California Public Employees' Retirement System20231.03x0.00x
Canaan XII L.P.LPs: Los Angeles County Employees Retirement Association20203.4%1.10x0.00x
Canaan XI, L.P.LPs: Los Angeles County Employees Retirement Association20179.7%1.68x0.06x
Canaan IXLPs: The Regents of the University of California, Hawaii Employees' Retirement System201219.1%2.04x0.93x
Canaan VIII, L.P.LPs: The Regents of the University of California, Hawaii Employees' Retirement System20078.9%1.44x1.24x
Canaan Equity Partners VIILPs: The Regents of the University of California200516.0%2.44x1.50x
Canaan VII, L.P.LPs: The Regents of the University of California, Los Angeles County Employees Retirement Association, Hawaii Employees' Retirement System200514.6%2.53x2.33x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

Frequently asked questions

How many investments has Canaan Partners made?
Canaan Partners has 391 tracked investments, 18 of which have exited via acquisition or IPO, including 18 dated in the last 24 months.
What stage does Canaan Partners invest at?
Canaan Partners invests at the Pre-Seed, Seed, Series A stages.
What is Canaan Partners's typical check size?
Canaan Partners typically writes checks of $500K – $20M.
What sectors does Canaan Partners focus on?
Canaan Partners focuses on Biotech, Cloud Computing, Consumer, Deep Tech, Digital Health, E-commerce, Enterprise Software, Fintech, Gaming, Healthtech, Medical Devices.
Where is Canaan Partners located?
Canaan Partners is headquartered in Stamford, US.
Does Canaan Partners lead rounds?
Yes, Canaan Partners leads investment rounds.
Who does Canaan Partners co-invest with?
Canaan Partners most often shares deals with Connecticut Innovations, Evolution VC Partners, New Enterprise Associates (NEA), among 553 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Zuckerberg's Puerto Rico VR video was in poor taste but uncharacteristic for him: Canaan Partners' Maha Ibrahim

Maha Ibrahim · cnbc.com

Wende Hutton, Canaan Partners

Life Science Washington · Wende Hutton

Deepak Kamra, Canaan Partners: Innovation

Tech4Obama · Deepak Kamra

Deepak Kamra, Canaan Partners: Keys to Success

Tech4Obama · Deepak Kamra

Deepak Kamra, Canaan Partners: Lessons Learned

Tech4Obama · Deepak Kamra

Deepak Kamra, Canaan Partners: Rapid Fire Questions

Tech4Obama · Deepak Kamra

Images

Canaan Partners photoCanaan Partners photoCanaan Partners photoCanaan Partners photoCanaan Partners photoCanaan Partners photoX profile banner

Co-investors · 265

New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

$200K – $40M
RA Capital

RA Capital invests in public and private healthcare and life science companies developing pharmaceuticals, medical devices, and diagnostic tools. The firm operates as a crossover fund across multiple investment stages.

Connecticut Innovations

Connecticut Innovations is the state of Connecticut's investment arm, providing capital and strategic support to early stage and growth companies across multiple funds.

$500K – $2M
Insight Partners

Insight Partners is an investment firm focused on accelerating revenue and profit growth in software companies, providing capital and operational support through its Insight Onsite team.

$120M – $350M
Lightspeed Venture Partners

Lightspeed is a global venture capital firm that has spent over two decades backing innovative companies as an early and first investor.

Both backed · 6
$1.7M – $87M
Khosla Ventures

Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.

$5K – $50M
Coatue Management

Coatue Management is a technology-focused investment firm that invests in innovation across both public and private markets with responsible risk management.

Both backed · 6
$1M – $20M
Norwest Venture Partners

Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.

$10M – $30M
F-Prime Capital

F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.

$3M – $10M
August Capital

August Capital is a venture capital firm that invests in a small number of companies, providing hands-on support to entrepreneurs building their businesses.

$1M – $15M
Comcast Ventures

Comcast Ventures is the venture investing arm of Comcast NBCUniversal, backing early- to growth-stage companies across sectors relevant to Comcast's future business, and offering portfolio companies access to the parent company's expertise, scale, network, and resources.

$2M – $15M
ARCH Venture Partners

ARCH Venture Partners is a venture capital firm that backs and helps build transformational companies, with a strong focus on the life sciences and biotech sector.

$50K – $250M
253 more co-investors

OrbiMedOUP (Osage University Partners)Bessemer Venture PartnersAccelFelicis VenturesKleiner PerkinsSpark CapitalCorrelation Ventures5AM VenturesSofinnova VenturesNextech InvestLightstone VenturesAndreessen HorowitzGeneral CatalystGV (Google Ventures)Redpoint VenturesDCVC (Data Collective)Battery VenturesSoftBank Vision FundIntel CapitalShasta VenturesNyca PartnersFJ LabsGreycroftScale Venture PartnersAcrew CapitalUS Venture PartnersInspired CapitalDreamers VCTribeca Venture PartnersRoot Ventures Manager, LlcAdvance Venture PartnersIn-Q-TelConductive VenturesAlta PartnersKaiser Permanente VenturesIndex VenturesFirst Round CapitalGreat Oaks Venture CapitalACME CapitalRRE VenturesFundersClubHeadlineCota CapitalSierra VenturesRevolutionAtlas VentureSocial Leverage500 GlobalWinklevoss CapitalWebb Investment NetworkDnx VenturesTorch CapitalNewView CapitalXYZ Venture CapitalZeev VenturesNext Coast VenturesMassMutual VenturesNational Grid PartnersSquare Peg CapitalFontinalis PartnersSR One Capital ManagementThe Column GroupThird Rock VenturesNew Leaf Venture PartnersVida VenturesBase Venture Management, Inc.Pontifax Venture CapitalThompson Hutton, LLCAvoro Capital AdvisorsNovo HoldingsSequoia CapitalCraft VenturesFounder CollectiveFoundation CapitalBoxGroupTrue VenturesSound VenturesCRV (Charles River Ventures)Plug and Play VenturesQuiet CapitalFirstMark CapitalOffline VenturesMayfield FundLiquid VenturesAME Cloud VenturesPICUS CAPITALTrinity VenturesTrajectory VenturesNext47VenrockPolaris PartnersDN CapitalBase10 PartnersBlockchain CapitalCyberstartsPrimary Venture PartnersCostanoa VenturesCiti Venturesboldstart venturesRenegade PartnersPelion Venture PartnersDigital Currency GroupEnergy Impact PartnersAcequia Capital (AceCap)Flourish VenturesWork-BenchCisco InvestmentsTusk Venture PartnersMango CapitalStorm VenturesPitangoFlare Capital PartnersTen ElevenSutter Hill VenturesJAZZ Venture PartnersEQT Life SciencesIndicator VenturesVersant VenturesWalden CatalystDeerfield Management CompanyTola CapitalvenBio PartnersMithril Capital ManagementDomain AssociatesAbingworthClearvision VenturesBlueYard CapitalTwo Bear CapitalOne Planet GroupAccess IndustriesHatteras Venture PartnersAdvent Life SciencesMTECH CAPITALRiverVest Venture PartnersMomenta VenturesIA Capital GroupVensana CapitalVertical Venture PartnersBrandProject CapitalCasdin CapitalJMI EquityRET VenturesAdjuvant CapitalEmerson Collective InvestingGreylock PartnersAlumni VenturesLong Journey VenturesNotable CapitalUncork CapitalBenchmarkSapphire VenturesPartech VenturesHCVCSciFi VCForerunner VenturesFifth WallPrecursor VenturesEmergence Capital PartnersObvious VenturesAdditionResolute VenturesBowery CapitalBonfire VenturesCrosslink CapitalParadigm75 & SunnyTribe Capital FirstlookGeneral PartnershipChemistryAngelPadEclipse VenturesFuel CapitalBetter Tomorrow VenturesOperator CollectiveBallistic Ventures8-Bit CapitalBaseline VenturesZetta Venture PartnersWildcat Venture PartnersCompany CapitalAmerican Express Ventures (Amex)Xtripe AngelsThe Finger GroupNGP CapitalHouseZ47MischiefS28 CapitalRavelin CapitalRubicon Venture CapitalOrigin VenturesVertex Ventures Sea Management Pte. Ltd.G2 Venture PartnersParade VenturesArtis VenturesAngular VenturesAZ-VCS32WestWave CapitalAI FundGE VenturesPaladin Capital GroupMiramar Venture PartnersSpace Tech VenturesEpisode1Illuminate VenturesSofinnova PartnersGrotech VenturesJohnson & Johnson Innovation – JJDCNazcaHelion Venture PartnersRedpoint eventuresSpace CapitalKOMPAS VCANIMO VenturesAutotech VenturesXSeed CapitalAsset Management VenturesXAngeStanford UniversityPivotal Life SciencesAcrobator VenturesMorgenthalerFrazier Healthcare PartnersGlencrest GroupNorthside VenturesTop Tier Capital PartnersAnkona CapitalPritzker Group Venture CapitalSmartStart FundDolby Family VenturesOmega FundsTunitas VenturesJefferiesNorthwestern Mutual Accelerator125 VenturesHealthQuest CapitalStarVest Partnersalpha4 venturesALLVPMerian VenturesStaircase VenturesWestlake Village BioPartnersGoldcrest CapitalOkapi Venture CapitalD.E. ShawStartup Capital VenturesPappas CapitalUnion Square Advisors LLCAvedro, Inc.Red Tree VentureBioInnovation Capital

Firms observed investing alongside Canaan Partners, from public investor directories. Shared companies are the overlap with Canaan Partners's recorded portfolio.

Similar investors

Featured in lists